Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of the change of Mr Chew Soo Lin's interest
Issuer & Securities
CHINA MEDICAL (INTERNATIONAL) GROUP LIMITED
CHINA MED (INTL) W201029 - SG5FF2000003 - 1F6W
CHINA MEDICAL (INTL) GROUP LTD - SG1T21929867 - 5IB
CHINA MED (INTL) W180329 - SG9QB8991245 - 5VNW
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer
Date &Time of Broadcast
Announcement Sub Title
Disclosure of the change of Mr Chew Soo Lin's interest
Submitted By (Co./ Ind. Name)
Tan Swee Gek
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the Sponsor) for compliance with the Singapore Exchange Securities Trading Limited (the SGX-ST) Listing Manual Section B: Rules of Catalist.
The Sponsor has not verified the contents of this announcement.
This announcement has not been examined or approved by the SGX-ST. The Sponsor and the SGX-ST assume no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Lance Tan, Director, Continuing Sponsorship (Mailing Address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and E-mail: email@example.com).
Person(s) giving notice
Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1)
Date of receipt of notice by Listed Issuer
eFORM1V2 - Mr Chew.2.FINAL.pdf
if you are unable to view the above file, please click the link below.
_eFORM1V2 - Mr Chew.2.FINAL.pdf
Total size =140K